Exousia Pro

St. Petersburg, United States Founded: 2024 • Age: 2 yrs Acquired By Medical Marijuana
Exosome-based therapeutics for glioblastoma are developed using plant materials.

About Exousia Pro

Exousia Pro is a company based in St. Petersburg (United States) founded in 2024 was acquired by Medical Marijuana in January 2025.. Exousia Pro has completed 1 acquisition, including Lamy. Exousia Pro offers products and services including Exosome Manufacturing Process and Proprietary Loading Technology. Exousia Pro operates in a competitive market with competitors including Modifi Bio, Biodexa Pharmaceuticals, OncoSynergy, CNS Pharmaceuticals and Plex Pharmaceuticals, among others.

  • Headquarter St. Petersburg, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Medical Marijuana

    (Jan 06, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Exousia Pro

Exousia Pro offers a comprehensive portfolio of products and services, including Exosome Manufacturing Process and Proprietary Loading Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Patented process using plant-based materials for exosome production.

Technology to infuse molecules like drugs and DNA into exosomes.

Funding Insights of Exousia Pro

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Exousia Pro

Exousia Pro has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medical Marijuana. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Manufacturer of cannabis focused products
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Exousia Pro

Exousia Pro has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lamy. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
High-quality writing instruments and digital tools are manufactured.
1930
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Exousia Pro

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Exousia Pro Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Exousia Pro

Exousia Pro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Modifi Bio, Biodexa Pharmaceuticals, OncoSynergy, CNS Pharmaceuticals and Plex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of therapeutics for the treatment of cancer
domain founded_year HQ Location
Therapeutics for aggressive rare brain cancers are developed.
domain founded_year HQ Location
Resistance mechanism inhibitors for cancer treatment are developed.
domain founded_year HQ Location
Treatments for brain and central nervous system cancers are developed.
domain founded_year HQ Location
Discovering small molecules for diseases caused by protein misfolding such as Parkinson's.
domain founded_year HQ Location
Small molecule therapeutics for difficult-to-treat cancers are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Exousia Pro

Frequently Asked Questions about Exousia Pro

When was Exousia Pro founded?

Exousia Pro was founded in 2024.

Where is Exousia Pro located?

Exousia Pro is headquartered in St. Petersburg, United States. It is registered at St. Petersburg, Florida, United States.

Who is the current CEO of Exousia Pro?

Michael Sheikh is the current CEO of Exousia Pro.

What does Exousia Pro do?

Exousia Pro was founded in 2024 and is based in St. Petersburg, United States. Operations in the biotechnology sector center on exosome-based therapeutics for cancer treatment. A mammalian exosomal technology platform is utilized, incorporating plant-derived materials to engineer exosomes targeted at glioblastoma. Development efforts focus on oncology applications, with leadership directed by CEO Michael Sheikh.

Who are the top competitors of Exousia Pro?

Exousia Pro's top competitors include Modifi Bio, Diakonos and Biodexa Pharmaceuticals.

What products or services does Exousia Pro offer?

Exousia Pro offers Exosome Manufacturing Process and Proprietary Loading Technology.

How many acquisitions has Exousia Pro made?

Exousia Pro has made 1 acquisition, including Lamy.

Who are Exousia Pro's investors?

Exousia Pro has 1 investor. Key investors include Medical Marijuana.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available